Quotient Limited - Ordinary Shares (QTNT): Price and Financial Metrics
QTNT Price/Volume Stats
| Current price | $0.38 | 52-week high | $105.20 |
| Prev. close | $0.37 | 52-week low | $0.18 |
| Day low | $0.32 | Volume | 5,811,400 |
| Day high | $0.48 | Avg. volume | 437,886 |
| 50-day MA | $1.61 | Dividend yield | N/A |
| 200-day MA | $12.75 | Market Cap | 980.40K |
QTNT Stock Price Chart Interactive Chart >
Quotient Limited - Ordinary Shares (QTNT) Company Bio
Quotient Limited develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwide. The company was founded in 2007 and is based in Penicuik, the United Kingdom.
Latest QTNT News From Around the Web
Below are the latest news stories about QUOTIENT LTD that investors may wish to consider to help them evaluate QTNT as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayWe're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Tuesday morning! |
Quotient Limited Announces Intent to Voluntary Delist from the Nasdaq Global MarketJERSEY, Channel Islands, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the "Company") today announced that it has given formal notice to the Nasdaq Stock Market LLC ("Nasdaq") of its intention to voluntarily delist its ordinary shares from the Nasdaq Global Market. In order to implement the delisting, the Company intends to file a Form 25 with the Securities and Exchange Commission (the "SEC") on or about December 27, 2022. The delisting of the Company's ordinary shares will |
Quotient Second Quarter 2023 Earnings: Revenues Miss ExpectationsQuotient ( NASDAQ:QTNT ) Second Quarter 2023 Results Key Financial Results Revenue: US$8.86m (down 6.5% from 2Q 2022... |
Quotient Limited Announces Reverse Stock Split Effective TodayJERSEY, Channel Islands, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the "Company"), a commercial-stage diagnostics company, today announced that a reverse split of its ordinary shares, nil par value ("Ordinary Shares"), at a ratio of 1-for-40 became effective following close of trading on the Nasdaq Global Market today. The Company's Ordinary Shares will begin trading on a split-adjusted basis when the market opens on November 3, 2022 under the existing trading symbol, "Q |
Quotient Limited Announces Intent to Effect Reverse Stock SplitJERSEY, Channel Islands, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the "Company"), a commercial-stage diagnostics company, today announced that it will effect a one-for-40 reverse stock split ("Reverse Stock Split") of its ordinary shares, nil par value ("Ordinary Shares") that will become effective on November 2, 2022 at 5:01 p.m. Eastern Time, after the close of trading on The Nasdaq Global Market ("Nasdaq"). The Company's Ordinary Shares are expected to begin trading |
QTNT Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | -51.90% |
| 1-year | -97.53% |
| 3-year | -99.88% |
| 5-year | -99.87% |
| YTD | 0.00% |
| 2022 | -99.63% |
| 2021 | -50.29% |
| 2020 | -45.22% |
| 2019 | 55.39% |
| 2018 | 23.64% |
Continue Researching QTNT
Want to see what other sources are saying about Quotient Ltd's financials and stock price? Try the links below:Quotient Ltd (QTNT) Stock Price | Nasdaq
Quotient Ltd (QTNT) Stock Quote, History and News - Yahoo Finance
Quotient Ltd (QTNT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...